date,title,source
Oct-24-18,Immutep Announces Data Presentations at Upcoming Industry Conferences,GlobeNewswire
Oct-30-18,Is Immutep Limited (ASX:IMM) Excessively Paying Its CEO?,Simply Wall St.
Nov-01-18,Operational Update,GlobeNewswire
Nov-12-18,Immutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting,GlobeNewswire
Nov-27-18,New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented at the 4th Annual ICI Europe Summit,GlobeNewswire
Dec-19-18,"Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital",GlobeNewswire
